EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY 4.0

Clinical Insights Into the COL4A3 p.Gly407Arg Variant in Alport Syndrome

Ana Marta Gomes iD, Cláudia Falcão Reis iD, Joana Dias iD, Pedro Moreira Martins iD, Nuno Medeiros iD, Graça Ferreira iD, Vitória Faria iD, Jorge Malheiro iD, Carolina Lemos iD, Daniela Lopes, Idalina Beirão iD

Kidney360 · 2026-08 · 7 (8) · 1835-1841

DOI: 10.34067/kid.0000001184 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Kidney360, online erschienen am 03.04.2026. Verfasst von Ana Marta Gomes und 10 weiteren Autor:innen. Beteiligte Einrichtung: Serviço de Nefrologia, Unidade Local de Saúde Gaia/Espinho, Vila Nova de Gaia, Portugal. Hauptthemen laut MEDLINE: Nephritis, Hereditary, Collagen Type IV, Autoantigens. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Instituto de Ciências Biomédicas Abel Salazar, Universidade do Porto, Fundação para a Ciência e a Tecnologia.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Key Points Phenotypic variability remains significant among patients with the monoallelic COL4A3 p.Gly407Arg variant, despite shared environmental backgrounds. Proteinuria ≥500 mg/g is a strong predictor of renal function decline and adverse outcomes, highlighting its value as a key prognostic marker. Early nephrologic monitoring and timely initiation of renoprotective therapies, such as renin-angiotensin-aldosterone system inhibitor may delay progression to kidney failure.

Background

Alport syndrome is a hereditary nephropathy caused by pathogenic variants in the COL4A3 , COL4A4 , or COL4A5 genes, encoding type 4 collagen chains that are essential for glomerular basement membrane integrity. The missense pathogenic variant p.Gly407Arg in COL4A3 has been reported in Portuguese families, but detailed phenotypic characterization remains limited. This study aimed to describe the renal and extrarenal manifestations and identify predictors of renal outcomes in a cohort of patients carrying the COL4A3 p.Gly407Arg variant.

Methods

We conducted a retrospective observational study including 62 patients from 25 families followed at a tertiary nephrology center in northern Portugal between 2007 and 2025 with genetically confirmed autosomal dominant Alport syndrome due to monoallelic COL4A3 p.Gly407Arg pathogenic variant. Demographic, clinical, laboratory, audiologic, and ophthalmologic data were analyzed. Renal events were defined as incident kidney failure, eGFR

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Nephritis, HereditaryCollagen Type IVAutoantigensHumansFemaleMaleRetrospective StudiesAdultMiddle AgedProteinuriaPortugalPhenotypeGlomerular Filtration RateMutation, MissenseDisease Progression

Stichwörter der Autor:innen

Alport syndrome

Substanzen

Collagen Type IVtype IV collagen alpha3 chainAutoantigens

Autor:innen und Institutionen

  • Serviço de Nefrologia, Unidade Local de Saúde Gaia/Espinho, Vila Nova de Gaia, Portugal.
  • Unit for Multidisciplinary Research in Biomedicine (UMIB), School of Medicine and Biomedical Sciences (ICBAS), University of Porto, Porto, Portugal.
  • ITR - Laboratory for Integrative and Translational Research in Population Health, Porto, Portugal.
  • Centro Académico Clínico Egas Moniz Health Alliance, Campus Universitário Santiago, Aveiro, Portugal.
  • Serviço de Genética Médica, Centro de Genética Médica Jacinto Magalhães, Unidade Local de Saúde de Santo António, Porto, Portugal.
  • European Rare Kidney Reference Center (ERKNet), Centro Hospitalar Universitário do Porto, Unidade Local de Saúde de Santo António, Porto, Portugal.

ORCID-Profile: Ana Marta Gomes, Cláudia Falcão Reis, Joana Dias, Pedro Moreira Martins, Nuno Medeiros, Graça Ferreira, Vitória Faria, Jorge Malheiro, Carolina Lemos, Idalina Beirão

Förderung

  • Instituto de Ciências Biomédicas Abel Salazar, Universidade do Porto
  • Fundação para a Ciência e a Tecnologia

Zitieren

APA

Gomes, A. M., Reis, C. F., Dias, J., Martins, P. M., Medeiros, N., Ferreira, G., Faria, V., Malheiro, J., Lemos, C., Lopes, D., & Beirão, I. (2026). Clinical Insights Into the COL4A3 p.Gly407Arg Variant in Alport Syndrome. Kidney360, 7(8), 1835-1841. https://doi.org/10.34067/kid.0000001184

Vancouver

Gomes AM, Reis CF, Dias J, Martins PM, Medeiros N, Ferreira G, et al. Clinical Insights Into the COL4A3 p.Gly407Arg Variant in Alport Syndrome. Kidney360. 2026;7(8):1835-1841. doi:10.34067/kid.0000001184

BibTeX
@article{Gomes2026,
  author = {Gomes, Ana Marta and Reis, Cláudia Falcão and Dias, Joana and Martins, Pedro Moreira and Medeiros, Nuno and Ferreira, Graça and Faria, Vitória and Malheiro, Jorge and Lemos, Carolina and Lopes, Daniela and Beirão, Idalina},
  title = {Clinical Insights Into the COL4A3 p.Gly407Arg Variant in Alport Syndrome},
  journal = {Kidney360},
  year = {2026},
  volume = {7},
  number = {8},
  pages = {1835--1841},
  doi = {10.34067/kid.0000001184}
}
Kostenlos starten →